Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Corning, Sartorius Stedim Enter Cell Culture Product Pact | Contract Pharma
Breaking News, Collaborations & Alliances

Corning, Sartorius Stedim Enter Cell Culture Product Pact

Corning, Inc. and Sartorius Stedim Biotech have entered a marketing and branding collaboration to offer a full range of cell culture products through a combined product catalogue.

Corning, Inc. and Sartorius Stedim Biotech have entered a marketing and branding collaboration to offer a full range of cell culture products through a combined product catalogue. The companies will work together on marketing and sales initiatives, as well as explore options for future R&D efforts and joint product development.

“As competitive pressures in the cell culture industry continue to evolve and increase, it is critical that we are able to offer customers a full range of cell culture lab products spanning basic research to full scale production,” said Thomas Appelt, vice president and general manager, Corning Life Sciences.

“Our collaboration with another industry leader such as Sartorius Stedim Biotech will strongly position both companies for future success. Both companies are leaders in single-use technology and can serve the global cell culture community with platforms for scalable solutions for both attached cells and cells in suspension,” said Reinhard Vogt, executive vice president of Sartorius Stedim Biotech.

Click here to find out more about Sartorius Stedim Biotech

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters